| 1 |
Han D, Gong H, Wei Y, Xu Y, Zhou X, Wang Z, Feng F. Hesperidin inhibits lung fibroblast senescence via IL-6/STAT3 signaling pathway to suppress pulmonary fibrosis. Phytomedicine 2023;112:154680. [PMID: 36736168 DOI: 10.1016/j.phymed.2023.154680] [Reference Citation Analysis]
|
| 2 |
Li H, Kim JA, Jo S, Lee H, Kim K, Choi S, Suh SH. Modafinil exerts anti-inflammatory and anti-fibrotic effects by upregulating adenosine A2A and A2B receptors.. [DOI: 10.21203/rs.3.rs-2606041/v1] [Reference Citation Analysis]
|
| 3 |
Park SJ, Hahn HJ, Oh SR, Lee HJ. Theophylline Attenuates BLM-Induced Pulmonary Fibrosis by Inhibiting Th17 Differentiation. Int J Mol Sci 2023;24. [PMID: 36674533 DOI: 10.3390/ijms24021019] [Reference Citation Analysis]
|
| 4 |
Zhang J, Zhang Y, Wang Z, Zhao J, Li Z, Wang K, Tian L, Yao B, Wu Q, Wang T, Wang J. Genes related to N6-methyladenosine in the diagnosis and prognosis of idiopathic pulmonary fibrosis. Front Genet 2022;13:1102422. [PMID: 36685949 DOI: 10.3389/fgene.2022.1102422] [Reference Citation Analysis]
|
| 5 |
Yue-Liang Yue, Meng-Yu Zhang, Jian-Yu Liu, Li-Jun Fang, Yi-Qing Qu. The role of autophagy in idiopathic pulmonary fibrosis: from mechanisms to therapies. Ther Adv Respir Dis 2022;16:17534666221140972. [PMID: 36468453 DOI: 10.1177/17534666221140972] [Reference Citation Analysis]
|
| 6 |
Cui E, Zhang L, Pan X, Zhang Q, Zhang L, Wu F, Chen N, Lv L, Chen W, Chen H, Lin A, Wang F, Liang J, Pan R. RNA-Sequencing approach for exploring the therapeutic effect of umbilical cord mesenchymal stem/stromal cells on lipopolysaccharide-induced acute lung injury. Front Immunol 2022;13:1021102. [DOI: 10.3389/fimmu.2022.1021102] [Reference Citation Analysis]
|
| 7 |
Shao M, Yang S, Zheng A, Wu Z, Chen M, Yao R, Shi Y, Chen G. Pathophysiological Changes in Rhesus Monkeys with Paraquat-Induced Pulmonary Fibrosis. Lung 2022;200:549-60. [PMID: 36163517 DOI: 10.1007/s00408-022-00572-9] [Reference Citation Analysis]
|
| 8 |
Kolios G, Paspaliaris V. Mesenchyme Stem Cell-Derived Conditioned Medium as a Potential Therapeutic Tool in Idiopathic Pulmonary Fibrosis. Biomedicines 2022;10:2298. [DOI: 10.3390/biomedicines10092298] [Reference Citation Analysis]
|
| 9 |
Yang Y, Liu Y, Chai Y, Liu K, Hu W, Zhao K, Zhu Y, Gao P, Huang Q, Zhang C. Exosomes in pathogenesis, diagnosis, and treatment of pulmonary fibrosis. Front Pharmacol 2022;13:927653. [DOI: 10.3389/fphar.2022.927653] [Reference Citation Analysis]
|
| 10 |
Ma H, Liu S, Li S, Xia Y. Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis. Front Pharmacol 2022;13:918771. [PMID: 35721111 DOI: 10.3389/fphar.2022.918771] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 11 |
Igai Y, Porter SE. Development and applicability of a dignity-centred palliative care programme for people with idiopathic pulmonary fibrosis: A qualitative-driven mixed methods study. Nurs Open 2023;10:8-23. [PMID: 35726124 DOI: 10.1002/nop2.1274] [Reference Citation Analysis]
|
